Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-122434
Filing Date
2023-11-30
Accepted
2023-11-30 16:16:11
Documents
4
Effectiveness Date
2023-11-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2330984d1_s8.htm S-8 45013
2 EXHIBIT 5.1 tm2330984d1_ex5-1.htm EX-5.1 58201
3 EXHIBIT 23.1 tm2330984d1_ex23-1.htm EX-23.1 2054
4 EX-FILING FEES tm2330984d1_ex-filingfees.htm EX-FILING FEES 23181
  Complete submission text file 0001104659-23-122434.txt   129610
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275813 | Film No.: 231456064
SIC: 2836 Biological Products, (No Diagnostic Substances)